Access brought to you by: LOCKSS
Login
Sequential Therapy With Gefitinib After Platinum-Based Doublet Chemotherapy Led to a Significantly Longer PFS Than Chemotherapy Alone for Patients With Advanced NSCLC.
Gefitinib was Associated With Significantly Better OS Only for Patients With Advanced NSCLC of Adenocarcinoma Histology.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.